No. |
著者名 |
演題名 |
掲載誌名 |
号 |
ページ |
年 |
1 |
Hirakata Y, Tomono K, Tateda K, Matsumoto T, Furuya N, Shimoguchi K, Kaku M and Yamaguchi K |
Role of bacterial association with Kupffer cells in occurrence of endogenous systemic bacteremia |
Infect Immun |
59 |
289-294 |
1991 |
2 |
Miyazaki S, Miyazaki Y, Tsuji A, Nishida M and Goto S |
In vitro and in vivo studies of ME1228, a new parenteral cephalosporin with potent activity against Pseudomonas aeruginosa |
Antimicrob Agents Chemother |
35 |
1245-1246 |
1991 |
3 |
Miyazaki S, Miyazaki Y, Tsuji A, Nishida M and Yamaguchi K |
In vitro antibacterial activity of ME1207, a new oral cephalosporin |
Antimicrob Agents Chemother |
35 |
1691-1694 |
1991 |
4 |
Hirakata Y, Kaku M, Tomono K, Tateda K, Furuya N, Matsumoto T, Araki R and Yamaguchi K |
Efficacy of erythromycin lactobionate for treating Pseudomonas aeruginosa bacteremia in mice |
Antimicrob Agents Chemother |
36 |
1198-1203 |
1992 |
5 |
Goto S, Miyazaki S and Kaneko Y |
The in vitro activity of RP59500 against Gram-positive cocci |
J Antimicrob Chemother |
30 |
25-28 |
1992 |
6 |
Imada T, Miyazaki S, Nishida M, Yamaguchi K and Goto S |
In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116 |
Antimicrob Agents Chemother |
36 |
573-579 |
1992 |
7 |
Miyazaki S, Matsunaga T, Kobayashi I, Yamaguchi K and Goto S |
The other mediator for adherence of Haemophilus influenzae organisms without involvement of fimbriae |
Microbiol Immunol |
36 |
205-212 |
1992 |
8 |
Hirakata Y, Kaku M, Mizukane R, Ishida K, Furuya N, Matsumoto T, Tateda K and Yamaguchi K |
Potential effects of erythromycin on host defense systems and virulence of Pseudomonas aeruginosa |
Antimicrob Agents Chemother |
36 |
1922-1927 |
1992 |
9 |
Miyazaki S, Matsunaga T, Kawasaki K, Kobayashi I, Tada H, Yamaguchi K and Goto S |
Separate isolation of Clostridium difficile spores and vegetative cells from the feces of newborn infants |
Microbiol Immunol |
36 |
131-138 |
1992 |
10 |
Furuya N, Hirakata Y, Tomono K, Matsumoto T, Tateda K, Kaku M and Yamaguchi K |
Mortality rates amongst mice with endogenous septicaemia caused by Pseudomonas aeruginosa isolates from various clinical sources |
J Med Microbiol |
39 |
141-146 |
1993 |
11 |
Hirakata Y, Kaku M, Furuya N, Matsumoto T, Tateda K and Yamaguchi K |
Contribution of difference in blood clearance of bacteria to development of systemic bacteremia |
J Med Microbiol |
38 |
337-344 |
1993 |
12 |
Miyazaki S, Ohno A, Kobayashi I, Uji T, Yamaguchi K and Goto S |
Cytotoxic effect of hemolytic culture supernatant from Enterococcus faecalis on mouse polymorphonuclear neutrophils and macrophages |
Microbiol Immunol |
37 |
265-270 |
1993 |
13 |
Tateda K, Tomono K, Hirakata Y, Furuya N, Sugahara K, Saniel MC, Tupasi TE and Yamaguchi K |
Prevalence of antimicrobial resistance in Haemophilus influenzae and Streptococcus pneumoniae; Comparison of clinical isolates of Japan and the Philippines |
Trop Med |
35 |
43-52 |
1993 |
14 |
Hirakata Y, Furuya N, Tateda K, Kaku M and Yamaguchi K |
In vivo production of exotoxin A and its role in endogenous Pseudomonas aeruginosa septicemia in mice |
Infect Immun |
61 |
2468-2473 |
1993 |
15 |
Matsumoto T, Kaku M, Furuya N, Usui T, Kohno S, Tomono K, Tateda K, Hirakata Y and Yamaguchi K |
Amphotericin B-induced resistance to Pseudomonas aeruginosa infection in mice |
J Antibiot |
46 |
777-784 |
1993 |
16 |
Tateda K, Hirakata Y, Furuya N, Ohno A and Yamaguchi K |
Effects of subMICs of erythromycin and other macrolide antibiotics on serum sensitivity of Pseudomonas aeruginosa |
Antimicrob Agents Chemother |
37 |
675-680 |
1993 |
17 |
Toyosawa T, Miyazaki S, Tsuji A, Yamaguchi K and Goto S |
In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin |
Antimicrob Agents Chemother |
37 |
60-66 |
1993 |
18 |
Fujii K, Tsuji A, Miyazaki S, Yamaguchi K and Goto S |
In vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivatives |
Antimicrob Agents Chemother |
38 |
1118-1122 |
1994 |
19 |
Tsuji A, Kaneko Y, Yamaguchi K and Goto S |
Correlation between the in vitro and in vivo effects of fourteen β-lactam compounds in mice with systemic infection |
Chemotherapy |
40 |
324-332 |
1994 |
20 |
Matsumoto T, Kaku M, Tateda K, Furuya N, Hirakata Y and Yamaguchi K |
Detection of antibody-coated bacteria in expectorated sputum for diagnosis of lower respiratory infections |
Microbiol Immunol |
38 |
287-293 |
1994 |
21 |
Tateda K, Ishii Y, Hirakata Y, Matsumoto T, Ohno A and Yamaguchi K |
Profiles of outer membrane proteins and lipopolysaccharide of Pseudomonas aeruginosa grown in the presence of sub-MICs of macrolide antibiotics and their relation to enhanced serum sensitivity |
J Antimicrob Chemother |
34 |
931-942 |
1994 |
22 |
Tateda K, Ishii Y, Matsumoto T, Hirakata Y and Yamaguchi K |
Suppressive effect of clindamycin on development of β-lactam resistance in Enterobacter cloacae ATCC 23355 |
J Antimicrob Chemother |
34 |
281-286 |
1994 |
23 |
Mizukane R, Hirakata Y, Kaku M, Ishii Y, Furuya N, Ishida K, Koga H, Kohno S and Yamaguchi K |
Comparative in vitro exoenzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa |
Antimicrob Agents Chemother |
38 |
528-533 |
1994 |
24 |
Kobayashi I, Hasegawa M, Miyazaki S, Nishida M and Goto S |
In vitro and in vivo changes of serotype in Pseudomonas aeruginosa isolates by anti-pseudomonal drugs |
J Antibiot |
47 |
72-79 |
1994 |
25 |
Iwasaki H, Miyazaki S, Tsuji A, Yamaguchi K and Goto S |
In vitro and in vivo antibacterial activities of Q-35, a novel fluoroquinolone |
Chemotherapy |
41 |
100-112 |
1995 |
26 |
Ishii Y, Ohno A, Taguchi H, Imajo S, Ishiguro M and Matsuzawa H |
Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A β-lactamase isolated from Escherichia coli |
Antimicrob Agents Chemother |
39 |
2269-2275 |
1995 |
27 |
Asahi Y, Miyazaki S and Yamaguchi K |
In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem |
Antimicrob Agents Chemother |
39 |
1030-1037 |
1995 |
28 |
Kodaka H, Ishikawa M, Iwata M, Kashitani F, Mizuochi S and Yamaguchi K |
Evaluation of new medium with chromogenic substrates for members of the family Enterobacteriaceae in urine samples |
J Clin Microbiol |
33 |
199-201 |
1995 |
29 |
Ohno A, Isii Y, Tateda K, Matsumoto T, Miyazaki S, Yokota S and Yamaguchi K |
Role of LPS length in clearance rate of bacteria from the bloodstream in mice |
Microbiology |
141 |
2749-2756 |
1995 |
30 |
Hirakata Y, Furuya N, Tateda K, Matsumoto T and Yamaguchi K |
The influence of exo-enzyme S and proteases on endogenous Pseudomonas aeruginosa bacteraemia in mice |
J Med Microbiol |
43 |
258-261 |
1995 |
31 |
Ishida Y, Miyazaki S, Yamaguchi K and Goto S |
In vitro and in vivo activ-ity of DQ-2556, a new cephalosporin |
Chemotherapy |
41 |
5-13 |
1995 |
32 |
Matsumoto T, Tateda K, Ishii Y, Ohno A, Miyazaki S and Yamaguchi K |
In vitro and in vivo antibacterial activities of broad spectrum quinolones against clinical bacterial isolates |
Drugs |
49 |
219-221 |
1995 |
33 |
Miyazaki S, Matsumoto T, Tateda K, Ohno A and Yamaguchi K |
Role of exotoxin A in inducing severe Pseudomonas aeruginosa infections in mice |
J Med Microbiol |
43 |
169-175 |
1995 |
34 |
Hirakata Y, Furuya N, Tateda K and Yamaguchi K |
A protective role for lymphocytes in cyclophosphamide-induced endogenous bacteraemia in mice |
J Med Microbiol |
43 |
141-147 |
1995 |
35 |
Hirakata Y, Furuya N, Matsumoto T, Tateda K and Yamaguchi K |
Influence of various immunosuppressive agents on the occurrence of endogenous bacteraemia in mice |
J Med Microbiol |
42 |
181-185 |
1995 |
36 |
Tsuji M, Ishii Y, Ohno A, Miyazaki S and Yamaguchi K |
In vitro and in vivo antibacterial activities of S-1090, a new oral cephalosporin |
Antimicrob Agents Chemother |
39 |
2544-2551 |
1995 |
37 |
Hirakata Y, Furuya N, Matsumoto T, Tateda K and Yamaguchi K |
The influence of immunosuppressive agents on the immune system of mice |
Immunol Infect Dis |
5 |
88-93 |
1995 |
38 |
Tateda K, Takashima K, Miyazaki H, Matsumoto T, Hatori T and Yamaguchi K |
Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model |
Antimicrob Agents Chemother |
40 |
1520-1525 |
1996 |
39 |
Tateda K, Ishii Y, Matsumoto T, Furuya N, Nagashima M, Matsunaga T, Ohno A, Miyazaki S and Yamaguchi K |
Direct evidence for antipseudomonal activity of macrolides:exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin and azithromycin |
Antimicrob Agents Chemother |
40 |
2271-2275 |
1996 |
40 |
Tateda K, Matsumoto T, Miyazaki S and Yamaguchi K |
Lipopolysaccharide-induced lethality and cytokine production in aged mice |
Infect Immun |
64 |
769-774 |
1996 |
41 |
Hirakata Y, Furuya N, Matsumoto T, Tateda K and Yamaguchi K |
Experimental endogenous septicaemia caused by Klebsiella pneumoniae and Escherichia coli in mice |
J Med Microbiol |
44 |
211-214 |
1996 |
42 |
Takashima K, Tateda K, Matsumoto T, Ito T, Iizawa Y, Nakao M and Yamaguchi K |
Establishment of a model of penicillin-resistant Streptococcus pneumoniae pneumonia in healthy CBA/J mice |
J Med Microbiol |
45 |
319-322 |
1996 |
43 |
Hirakata Y, Furuya N, Iwata M, Kashitani F, Ishikawa M, Yumoto S, Yasui K, Endoh H, Marui A, Kaku M, Tateda K and Yamaguchi K |
Assessment of clinical significance of positive blood cultures of relatively low-virulence isolates |
J Med Microbiol |
44 |
195-198 |
1996 |
44 |
Miyazaki S, Matsumoto T, Tateda K and Yamaguchi K |
In vitro and in vivo evaluation of DU6859a, a new fluoroquinolone, among injectable antibacterials tested against clinical isolates |
J Infect Chemother |
2 |
148-155 |
1996 |
45 |
Miyazaki S, Nunoya T, Matsumoto T, Tateda K and Yamaguchi K |
New murine model of bronchopneumonia due to cell-bound Haemophilus influenzae |
J Infect Dis |
175 |
205-209 |
1997 |
46 |
Matsumoto T, Tateda K, Miyazaki S, Furuya N, Ohno A, Ishii Y, Hirakata Y and Yamaguchi K |
Immunomodulating effect of fosfomycin on gut-derived sepsis caused by Pseudomonas aeruginosa in mice |
Antimicrob Agents Chemother |
41 |
308-313 |
1997 |
47 |
Irie Y, Tateda K, Matsumoto T, Miyazaki S and Yamaguchi K |
Antibiotic MICs and short time-killing against Helicobacter pylori:therapeutic potential of kanamycin |
J Antimicrob Chemother |
40 |
235-240 |
1997 |
48 |
Matsumoto T, Tateda K, Miyazaki S, Furuya N, Ohno A, Ishii Y, Hirakata Y and Yamaguchi K |
Adverse effects of tumour necrosis factor in cyclophosphamide-treated mice subjected to gutderived Pseudomonas aeruginosa sepsis |
Cytokine |
9 |
763-769 |
1997 |
49 |
Miyazaki S, Domon H, Tateda K, Ohno A, Ishii Y, Matsumoto T, Furuya N and Yamaguchi K |
In vitro and in vivo antibacterial activities of CS-940, a new fluoroquinolone, against isolates from patients with respiratory infections |
Antimicrob Agents Chemother |
41 |
2582-2585 |
1997 |
50 |
Takashima K, Tateda K, Matsumoto T, Iizawa Y, Nakao M and Yamaguchi K |
Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice |
Infect Immun |
65 |
257-260 |
1997 |
51 |
Ohno A, Marui A, Castro ES, Reyes AA, Elio-Calvo D, Kasitani F, Ishii Y and Yamaguchi K |
Enteropathogenic bacteria in the La Paz river of Bolivia |
American J. Trop Med Hyg |
57 |
438-444 |
1997 |
52 |
Matsumoto T, Tateda K, Furuya N, Miyazaki S, Ohno A, Ishii Y, Hirakata Y and Yamaguchi K |
Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice |
J Med Microbiol |
47 |
303-308 |
1998 |
53 |
Matsumoto T, Tateda K, Miyazaki S, Furuya N, Ohno A, Ishii Y, Hirakata Y and Yamaguchi K |
Effect of immunisation with Pseudomonas aeruginosa on gut-derived sepsis in mice |
J Med Microbiol |
47 |
295-301 |
1998 |
54 |
Matsumoto T, Tateda K, Miyazaki S, Furuya N, Ohno A, Ishii Y, Hirakata Y and Yamaguchi K |
Effect of interleukin-10 on gut-derived sepsis caused by Pseudomonas aeruginosa in mice |
Antimicrob Agents Chemother |
42 |
2853-2857 |
1998 |
55 |
Yoshizumi S, Domon H, Miyazaki S and Yamaguchi K |
In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens |
Antimicrob Agents Chemother |
42 |
785-788 |
1998 |
56 |
Homma S, Takimoto E, Kawabata M, Kishi K, Tsuboi E, Narui K, Nakatani T, Inagawa Y, Tateda K and Yamaguchi K |
The first recognized patients with Legionella pneumophila serogroup 9 pneumonia in Japan |
J Infect Chemother |
4 |
214-218 |
1998 |
57 |
Ma L, Ishii Y, Ishiguro M, Matsuzawa H and Yamaguchi K |
Cloning and sequencing of the gene encoding Toho-2, a class A β-lactamase preferentially inhibited by tazobactam |
Antimicrob Agents Chemother |
42 |
1181-1186 |
1998 |
58 |
Hirakata Y, Izumikawa K, Yamaguchi T, Igimi S, Furuya N, Maesaki S, Tomono K, Yamada Y, Kohno S, Yamaguchi K and Kamihira S |
Adherence to and penetration of human intestinal Caco-2 epithelial cell monolayers by Pseudomonas aeruginosa |
Infect Immun |
66 |
1748-1751 |
1998 |
59 |
Yamaguchi K, Domon H, Miyazaki S, Tateda K, Ohno A, Ishii Y, Matsumoto T and Furuya N |
In vitro and in vivo antibacterial activities of CS-834, a new oral carbapenem |
Antimicrob Agents Chemother |
42 |
555-563 |
1998 |
60 |
Arakawa S, Matsui T, Kamidono S, Kawada Y, Kumon H, Hirai K, Hirose T, Matsumoto T, Yamaguchi K, Yoshida T, Watanabe K, Ueno K, Saito A and Teranishi T |
Derivation of a calculation formula for breakpoints of antimicrobial agents in urinary tract infections |
J Infect Chemother |
4 |
97-106 |
1998 |
61 |
Miyazaki S, Tateda K, Ohno A, Ishii Y, Matsumoto T, Furuya N and Yamaguchi K |
In vitro and in vivo antibacterial activities of quinupristin-dalfopristin, a novel injectable streptogramin, against gram-positive cocci and gram-negative respiratory tract pathogens |
J Infect Chemother |
4 |
64-70 |
1998 |
62 |
Tamura S, Miyazaki S, Tateda K, Ohno A, Ishii Y, Matsumoto T, Furuya N and Yamaguchi K |
In vivo antibacterial activities of sanfetrinem cilexetil, a new oral tricyclic antibiotic |
Antimicrob Agents Chemother |
42 |
1858-1861 |
1998 |
63 |
Tsuji M, Ishii Y, Ohno A, Miyazaki S and Yamaguchi K |
In vitro and in vivo antibacterial activities of S-4661, a new carbapenem |
Antimicrob Agents Chemother |
42 |
94-99 |
1998 |
64 |
Tateda K, Matsumoto T and Yamaguchi K |
Acute induction of interleukin-6 and biphasic changes of serum complement C3 by carrageenan in mice |
Mediators Inflam |
7 |
221-223 |
1998 |
65 |
Tateda K, Matsumoto T, Ishii Y, Furuya N, Ohno A, Miyazaki S and Yamaguchi K |
Serum cytokines in patients with Legionella pneumonia:Relative predominance of Th1-type cytokines |
Clin Diagn Lab Immunol |
5 |
401-403 |
1998 |
66 |
Tateda K, Murakami H, Ishii Y, Furuya N, Matsumoto T and Yamaguchi K |
Evaluation of clinical usefulness of the microplate agglutination test for serological diagnosis of Legionella pneumonia |
J Med Microbiol |
47 |
325-328 |
1998 |
67 |
Tomizawa H, Tateda K, Miyazaki S and Yamaguchi K |
Antibacterial activity of AM-1155 against penicillin-resistant Streptococcus pneumoniae |
J Antimicrob Chemother |
41 |
103-106 |
1998 |
68 |
Ishida Y, Kurosaka Y, Murakami Y, Otani T and Yamaguchi K |
Therapeutic effect of oral Levofloxacin, Ciprofloxacin and Ampicillin on experimental murine pneumonia caused by penicillin intermediate Streptococcus pneumoniae for which the minimum inhibitory concentrations of the quinolones are similar |
Chemotherapy |
45 |
183-191 |
1999 |
69 |
Miyazaki S, Matsumoto T, Furuya N, Tateda K and Yamaguchi K |
The pathogenic role of fimbriae of Haemophilus influenzae type b in murine bacteraemia and meningitis |
J Med Microbiol |
48 |
383-388 |
1999 |
70 |
Matsumoto T, Furuya N, Tateda K, Miyazaki S, Ohno A, Ishii Y, Hirakata Y and Yamaguchi K |
Effect of passive immunotherapy on murine gutderived sepsis caused by Pseudomonas aeruginosa |
J Med Microbiol |
48 |
765-770 |
1999 |
71 |
Kimura K, Miyazaki S, Tateda K, Matsumoto T, Tsujimoto S and Yamaguchi K |
Factors affecting the course and severity of transnasally induced Staphylococcus aureus pneumonia in mice |
J Med Microbiol |
48 |
1005-1010 |
1999 |
72 |
Tateda K, Matsumoto T, Miyazaki S and Yamaguchi K |
Efficacy of β-lactam antibiotics combined with gentamicin against penicillin-resistant pneumococcal pneumonia in CBA/J mice |
J Antimicrob Chemother |
43 |
367-371 |
1999 |
73 |
Matsumoto T, Tateda K, Miyazaki S, Furuya N, Ohno A, Ishii Y, Hirakata Y and Yamaguchi K |
Paradoxical synergistic effects of tumour necrosis factor and interleukin 1 in murine gutderived sepsis with Pseudomonas aeruginosa |
Cytokine |
11 |
366-372 |
1999 |
74 |
Miyazaki S, Ishii Y, Ohno A, Furuya N, Matsumoto T, Tateda K and Yamaguchi K |
In-vitro activities of 11 antibiotics against vancomycin-resistant enterococci isolated in Japan |
J Antimicrob Chemother |
44 |
415-416 |
1999 |
75 |
Ibuka A, Taguchi A, Ishiguro M, Fushinobu S, Ishii Y, Kamitori S, Okuyama K, Yamaguchi K, Konno M and Matsuzawa H |
Crystal structure of the E166A mutant of extended-spectrum β-lactamase Toho-1 at 1.8 A resolution |
J Mol Biol |
285 |
2079-2087 |
1999 |
76 |
Higashi Y, Watanabe A, Matsumoto Y, Watanabe Y and Ohno A |
Role of inhibition of penicillin binding proteins and cell wall cross-linking by β-lactam antibiotics in low- and high-level methicillin resistance of Staphylococcus aureus |
Chemotherapy |
45 |
37-47 |
1999 |
77 |
Matsumoto T, Tateda K, Miyazaki S, Furuya N, Ohno A, Ishii Y, Hirakata Y and Yamaguchi K |
Effect of antiflagellar human monoclonal antibody on gut-derived Pseudomonas aeruginosa sepsis in mice |
Clin Diagn Lab Immunol |
6 |
537-541 |
1999 |
78 |
Matsumoto T, Tateda K, Miyazaki S, Furuya N, Ohno A, Ishii Y, Hirakata Y and Yamaguchi K |
Fosfomycin alters lipopolysaccharide-induced inflammatory cytokine production in mice |
Antimicrob Agents Chemother |
43 |
697-698 |
1999 |
79 |
Yamaguchi K, Mathai D, Biedenbach DJ, Lewis MT, Gales AC and Jones RN |
Evaluation of the in vitro activity of six broad-spectrum β-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan |
Diagn Microbiol Infect Dis |
34 |
123-134 |
1999 |
80 |
Saito A, Inamatsu T, Okada J, Oguri T, Kanno H, Kusano N, Kumon H, Yamaguchi K, Watanabe A and Watanabe K |
Clinical breakpoints in pulmonary infections and sepsis: new antimicrobial agents and supplemental information for some agents already released |
J Infect Chemother |
5 |
223-226 |
1999 |
81 |
Hirakata Y, Ishii Y, Nakano M, Matsuda J, Ozaki Y, Mochida C, Iori F, Ma L, Izumikawa K, Yamaguchi T, Miyazaki Y, Maesaki S, Tomono K, Yamada Y, Yamaguchi K, Kamihira S and Kohno S |
Two sporadic cases of infections due to Klebsiella pneumoniae resistant to expanded-spectrum cephalosporins in Japan |
J Infect Chemother |
5 |
91-96 |
1999 |